Is it Possible to Differentiate between Angiotensin II Type 1 (AT1) Receptor Blockers in Normotensive Volunteers?

Author： AZIZI M. NICOLET L. CHATELLIER G. GUYENE T. T. HEMPENIUS J. MÉNARD J.

ISSN： 0803-7051

Source： Blood Pressure, Vol.9, Iss.1, 2000-05, pp. : 53-53

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

TRANSCEND Aftermath: Angiotensin II Type 1 Receptor Antagonists (Angiotensin Receptor Blockers) at the Clinical Crossroad

By Volpe Massimo

High Blood Pressure & Cardiovascular Prevention, Vol. 16, Iss. 1, 2009-05 ,pp. : 1-6

Adis International

Access to resources Recommend Favorite

By Alberto Corsini

High Blood Pressure & Cardiovascular Prevention, Vol. 11, Iss. 3, 2004-01 ,pp. : 117-121

Adis International

Access to resources Recommend Favorite

Differences Among Angiotensin II Type 1 Receptor Blockers: Characteristics of Candesartan Cilexetil

By UNGER THOMAS

Blood Pressure, Vol. 9, Iss. 1, 2000-05 ,pp. : 14-18

Informa Healthcare

Access to resources Recommend Favorite

Prescription Data Related to the Use of Calcium Channel Blockers, ACE Inhibitors and Angiotensin II Type 1 Receptor Antagonists (Angiotensin Receptor Blockers) in Combination Identify Savings Opportunities

By Carugo Stefano

High Blood Pressure & Cardiovascular Prevention, Vol. 16, Iss. 1, 2009-05 ,pp. : 21-26

Adis International

Access to resources Recommend Favorite

Association between Angiotensin II Type 1 Receptor Gene Polymorphisms and Ischemic Stroke: A Meta-Analysis

Cerebrovascular Diseases, Vol. 32, Iss. 5, 2011-10 ,pp. : 431-438

Karger

Access to resources Recommend Favorite